CORC

在结果中检索

CORC

浏览/检索结果: 共31条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Missing recognition of highway shading board based on deep convolution segmentation and correction 会议论文
Dalian, China, 2022-04-14
作者:  Dong, Yuanshuai;  Zhang, Yanhong;  Hou, Yun;  Tong, Xinlong;  Wu, Qingquan
收藏  |  浏览/下载：31/0  |  提交时间：2022/07/21
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
Minimizing Charging Delay for Directional Charging in Wireless Rechargeable Sensor Networks 会议论文
IEEE CONFERENCE ON COMPUTER COMMUNICATIONS (IEEE INFOCOM 2019), 2019-01-01
作者:  Lin, Chi;  Zhou, Yanhong;  Ma, Fenglong;  Deng, Jing;  Wang, Lei
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
IDENTIFICATION OF SIX DERMATOMYOSITIS SUBGROUPS USING PRINCIPAL COMPONENT ANALYSIS-BASED CLUSTER ANALYSIS 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Zhu, Huiyi;  Wu, Chanyuan;  Jiang, Nan;  Wang, Yanhong;  Zhao, Jiuliang
收藏  |  浏览/下载：12/0  |  提交时间：2020/01/03
BASELINE CHARACTERISTICS AND TREATMENTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS: THE CREDIT STUDY IN CHINA, 2016-2018 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Jiang, Nan;  Li, Mengtao;  Wang, Yanhong;  Zhao, Jiuliang;  Wang, Qian
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace